ArticleThe Lancet. Haematology2023

Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study.

Annie Cowan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.